Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.

Takano T, Tsukiyama-Kohara K, Hayashi M, Hirata Y, Satoh M, Tokunaga Y, Tateno C, Hayashi Y, Hishima T, Funata N, Sudoh M, Kohara M.

J Hepatol. 2011 Sep;55(3):512-21. doi: 10.1016/j.jhep.2010.12.011. Epub 2010 Dec 22.

PMID:
21184787
2.

Increase of oxidant-related triglycerides and phosphatidylcholines in serum and small intestinal mucosa during development of intestinal polyp formation in Min mice.

Ikeda K, Mutoh M, Teraoka N, Nakanishi H, Wakabayashi K, Taguchi R.

Cancer Sci. 2011 Jan;102(1):79-87. doi: 10.1111/j.1349-7006.2010.01754.x. Epub 2010 Oct 14.

3.

Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.

Weng L, Hirata Y, Arai M, Kohara M, Wakita T, Watashi K, Shimotohno K, He Y, Zhong J, Toyoda T.

J Virol. 2010 Nov;84(22):11761-70. doi: 10.1128/JVI.00638-10. Epub 2010 Sep 15.

4.

Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics.

Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, Proll SC, McDermott JE, Gritsenko MA, Zhang Q, Zhao R, Metz TO, Camp DG 2nd, Waters KM, Smith RD, Rice CM, Katze MG.

PLoS Pathog. 2010 Jan;6(1):e1000719. doi: 10.1371/journal.ppat.1000719. Epub 2010 Jan 8.

5.

Hepatitis C virus hijacks host lipid metabolism.

Syed GH, Amako Y, Siddiqui A.

Trends Endocrinol Metab. 2010 Jan;21(1):33-40. doi: 10.1016/j.tem.2009.07.005. Epub 2009 Oct 23. Review.

6.

Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome.

van der Meer-Janssen YP, van Galen J, Batenburg JJ, Helms JB.

Prog Lipid Res. 2010 Jan;49(1):1-26. doi: 10.1016/j.plipres.2009.07.003. Epub 2009 Jul 26. Review.

PMID:
19638285
7.

Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.

Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, Bantscheff M, Schirle M, Bouwmeester T, Mathy JE, Lin K, Compton T, Labow M, Wiedmann B, Gaither LA.

J Virol. 2009 Oct;83(19):10058-74. doi: 10.1128/JVI.02418-08. Epub 2009 Jul 15.

8.

Global analysis of triacylglycerols including oxidized molecular species by reverse-phase high resolution LC/ESI-QTOF MS/MS.

Ikeda K, Oike Y, Shimizu T, Taguchi R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 1;877(25):2639-47. doi: 10.1016/j.jchromb.2009.03.047. Epub 2009 Apr 7.

PMID:
19481987
9.

Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.

Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, Randall G.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7577-82. doi: 10.1073/pnas.0902693106. Epub 2009 Apr 17.

10.

Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication.

Vaillancourt FH, Pilote L, Cartier M, Lippens J, Liuzzi M, Bethell RC, Cordingley MG, Kukolj G.

Virology. 2009 Apr 25;387(1):5-10. doi: 10.1016/j.virol.2009.02.039. Epub 2009 Mar 21.

11.

A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RT.

Cell Host Microbe. 2009 Mar 19;5(3):298-307. doi: 10.1016/j.chom.2009.02.001.

12.

Targeted analysis of ganglioside and sulfatide molecular species by LC/ESI-MS/MS with theoretically expanded multiple reaction monitoring.

Ikeda K, Shimizu T, Taguchi R.

J Lipid Res. 2008 Dec;49(12):2678-89. doi: 10.1194/jlr.D800038-JLR200. Epub 2008 Aug 14.

13.

Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection.

Aizaki H, Morikawa K, Fukasawa M, Hara H, Inoue Y, Tani H, Saito K, Nishijima M, Hanada K, Matsuura Y, Lai MM, Miyamura T, Wakita T, Suzuki T.

J Virol. 2008 Jun;82(12):5715-24. doi: 10.1128/JVI.02530-07. Epub 2008 Mar 26.

14.

Targeting lipid metabolism in the treatment of hepatitis C virus infection.

Amemiya F, Maekawa S, Itakura Y, Kanayama A, Matsui A, Takano S, Yamaguchi T, Itakura J, Kitamura T, Inoue T, Sakamoto M, Yamauchi K, Okada S, Yamashita A, Sakamoto N, Itoh M, Enomoto N.

J Infect Dis. 2008 Feb 1;197(3):361-70. doi: 10.1086/525287.

15.

Basic analytical systems for lipidomics by mass spectrometry in Japan.

Taguchi R, Nishijima M, Shimizu T.

Methods Enzymol. 2007;432:185-211.

PMID:
17954218
16.

Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction.

Diamond DL, Jacobs JM, Paeper B, Proll SC, Gritsenko MA, Carithers RL Jr, Larson AM, Yeh MM, Camp DG 2nd, Smith RD, Katze MG.

Hepatology. 2007 Sep;46(3):649-57.

PMID:
17654742
17.

Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.

Inoue K, Umehara T, Ruegg UT, Yasui F, Watanabe T, Yasuda H, Dumont JM, Scalfaro P, Yoshiba M, Kohara M.

Hepatology. 2007 Apr;45(4):921-8.

PMID:
17393519
18.

Ceramide and sphingomyelin species of fibroblasts and neurons in culture.

Valsecchi M, Mauri L, Casellato R, Prioni S, Loberto N, Prinetti A, Chigorno V, Sonnino S.

J Lipid Res. 2007 Feb;48(2):417-24. Epub 2006 Nov 8.

19.

Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.

He Q, Suzuki H, Sharma N, Sharma RP.

Toxicol Sci. 2006 Dec;94(2):388-97. Epub 2006 Sep 7.

20.

Lipidomics of host-pathogen interactions.

Wenk MR.

FEBS Lett. 2006 Oct 9;580(23):5541-51. Epub 2006 Jul 13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk